Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Rapid screening of biologically active nucleases and isolation of nuclease-modified cells

Rapid screening of biologically active nucleases and isolation of nuclease-modified cells

US Patent 9121072 · Granted Sep 1, 2015

Estimated economic value: $7,447,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CRISPR-cas9 system and uses thereof2025
Method of inactivating a glucocorticoid receptor gene in an isolated cell2024
Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods 2023
Methods and compositions for engineering immunity2023
Artificial nucleases comprising engineered cleavage half-domains2023
Methods and compositions for gene inactivation2023
Method of making and using mammalian liver cells for treating hemophilia or lyso2023
Methods and compositions for treatment of a genetic condition2022
Targeted disruption of T cell receptor genes using engineered zinc finger protei2022
Methods and compositions for targeted cleavage and recombination2022
Methods and compositions for modulating PD12022
T cell modifying compounds and uses thereof2022